Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR132 | Q9UNW8 | 12/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | CMKLR2 | P46091 | 1/20 | 0.53 |
| ▸ | CMKLR1 | Q99788 | 1/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.50 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.48 |
| ▸ | ITGAV | P06756 | 1/20 | 0.48 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.46 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1123517 | 0.91 | PTPN1 (0.64) | GPR132PTPN1ITGB3ITGA2BITGB1 | |
| SCHEMBL1123192 | 0.88 | GPR132 (0.63) | GPR132PTPN1CMKLR2CMKLR1ITGB3 | |
| SCHEMBL1123431 | 0.85 | GPR132 (0.61) | GPR132PTPN1CMKLR2CMKLR1ITGB3 | |
| SCHEMBL1123228 | 0.84 | GPR132 (0.60) | GPR132PTPN1CMKLR2CMKLR1ITGB3 | |
| SCHEMBL1123378 | 0.82 | GPR132 (0.57) | GPR132PTPN1CMKLR2CMKLR1ITGB3 | |
| SCHEMBL1123050 | 0.81 | PTPN1 (0.69) | GPR132PTPN1ITGB3ITGA2BITGB1 | |
| SCHEMBL1122721 | 0.80 | PTPN1 (0.68) | GPR132PTPN1ITGB3ITGA2B | |
| SCHEMBL1123282 | 0.80 | PTPN1 (0.58) | GPR132PTPN1CMKLR2CMKLR1ITGB3 | |
| SCHEMBL1123437 | 0.79 | PTPN1 (0.67) | GPR132PTPN1ITGB3ITGA2BITGB1 | |
| SCHEMBL1123593 | 0.79 | NR4A1 (0.48) | NR4A1NR4A2NR4A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644321-B1 | NEW BENZAMIDES AS PPATY MODULATORS | S A L V A T LAB SA (ES) | 2011-02-09 | — | — | EP | disclosed |
| CN-1835914-A | New benzamides as PPAR[upsilon] modulators | S A L V A T LAB SA (ES) | 2006-09-20 | — | — | CN | disclosed |
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
| EP-1644321-A2 | NEW BENZAMIDES AS PPATY MODULATORS | LABORATORIOS S.A.L.V.A.T., S.A. (ES) | 2006-04-12 | — | — | EP | disclosed |
| WO-2004110983-A2 | NEW BENZAMIDES AS PPARϒ MODULATORS | LABORATORIOS S.A.L.V.A.T., S.A. (ES) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | GPR132 122/4885PTPN1 2708/4885CMKLR2 1279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.